86
88
Growth Score 86 in past quarter
-5 pts
Heat Score 88 in past quarter
51 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
291026
AstraZeneca Canada develops and distributes prescription pharmaceutical products and conducts clinical research.
About the Company
AstraZeneca Canada develops and distributes prescription pharmaceutical products and conducts clinical research across multiple therapeutic areas, including oncology, cardiovascular, renal, metabolic, respiratory, immunology, and rare diseases. The company manages a clinical research hub that coordinates global studies, with operational involvement
in clinical trials for conditions such as lung cancer, prostate cancer, chronic obstructive pulmonary disease, and severe asthma. It partners with healthcare institutions and research organizations to support trial execution and data collection. AstraZeneca Canada also incorporates technologies and capabilities from acquired entities, such as radioconjugate platforms used in cancer treatment.